The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Tuberculosis in Solid‐Organ Transplant Recipients: Consensus Statement of the Group for the Study of Infection in Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology
Abstract
Tuberculosis is a particularly important condition in solid-organ transplant recipients because of the delay in treatment caused by the difficulties involved in its diagnosis and because of the pharmacological toxicity associated with this treatment. Both treatment delay and toxicity are responsible for the many clinical complications of and high mortality associated with tuberculosis in this population. The Consensus Statement from the Spanish Group for the Study of Infectious Diseases in Transplant Recipients defines the indications for treatment of latent tuberculosis infection in solid-organ transplant recipients, especially in patients with a high risk of pharmacological toxicity, as is the case with liver recipients. We established a series of recommendations regarding the types of drugs and the duration of treatment of tuberculosis in solid-organ recipients, giving special attention to pharmacological interactions between rifampin and immunosuppressive drugs (cyclosporine, tacrolimus, rapamycin, and corticosteroids).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.167.4.603 · Cited by 1,944
Yee, D., Valiquette, C., Pelletier, M., Parisien, I., Rocher, I., & Menzies, D. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200206-626oc · Cited by 840
Singh, N., & Paterson, D. L. (1998) · Clinical Infectious Diseases · doi:10.1086/514993 · Cited by 573
Fluoroquinolones, tuberculosis, and resistance
Ginsburg, A. S., Grosset, J. H., & Bishai, W. R. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00671-6 · Cited by 403
European Best Practice Guidelines for Renal Transplantation (Part 2).
Berthoux, F. C., Abramowicz, D., Ekberg, H., Frei, U. A., Morales, J., Ølgaard, K., Paul, L., & Pontecelli, C. (2002) · Lund University Publications (Lund University) · Cited by 371
Mycobacterium tuberculosis Infection in Recipients of Solid Organ Transplants
Munoz, P., Rodriguez, C., & Bouza, E. (2005) · Clinical Infectious Diseases · doi:10.1086/427692 · Cited by 357
Aguado, J. M., Herrero, J. A., Gavald??, J., Torre-Cisneros, J., Blanes, M., Ruf??, G., Moreno, A., Gurgu??, M., Hayek, M., & Lumbreras, C. (1997) · Transplantation · doi:10.1097/00007890-199705150-00015 · Cited by 338
Self-citationGuide to Development of Practice Guidelines
Kish, M. A. (2001) · Clinical Infectious Diseases · doi:10.1086/319366 · Cited by 276
SECTION IV: Long-term management of the transplant recipient
(2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.suppl_4.3 · Cited by 243
Linezolid for the treatment of multidrug-resistant tuberculosis
Fortún, J., Martín-Dávila, P., Navas, E., Pérez-Elías, M. J., Cobo, J., Tato, M., De la Pedrosa, E. G.-G., Gómez-Mampaso, E., & Moreno, S. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki148 · Cited by 225
Self-citationPurpose of Quality Standards for Infectious Diseases
Gross, P. A., Barrett, T. L., Dellinger, E. P., Krause, P. J., Martone, W. J., McGowan, J. E., Sweet, R. L., & Wenzel, R. P. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.3.421 · Cited by 223
Risk factors for post-transplant tuberculosis
John, G. T., Shankar, V., Abraham, A. M., Mukundan, U., Thomas, P. P., & Jacob, C. K. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0600031148.x · Cited by 183
Practice Guidelines for the Treatment of Tuberculosis
Horsburgh, C. R., Feldman, S., & Ridzon, R. (2000) · Clinical Infectious Diseases · doi:10.1086/314007 · Cited by 131
Benito, N., Sued, O. G., Moreno, A. N., Horcajada, J. P., lez, J. G., Navasa, M., & Rimola, A. (2002) · Transplantation · doi:10.1097/00007890-200211270-00006 · Cited by 98
Self-citationTuberculosis in Heart Transplant Recipients
Munoz, P., Palomo, J., Munoz, R., Rodriguez-Cretxems, M., Peláez, T., & Bouza, E. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.2.398 · Cited by 94
Miró, J. M., Torre‐Cisneros, J., Moreno, A., Tuset, M., Quereda, C., Laguno, M., Vidal, E., Riveroa, A., González, J., Lumbreras, C., et al. (2005) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13076175 · Cited by 90
Self-citationProspective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy
Vikrant, S., Agarwal, S. K., Gupta, S. K., Bhowmik, D. M., Tiwari, S. C., Dash, S., Guleria, S., & Mehta, S. (2005) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2005.00103.x · Cited by 87
Meyers, B. R., Papanicolaou, G. A., Sheiner, P. A., Emre, S., & Miller, C. M. (2000) · Transplantation · doi:10.1097/00007890-200001150-00013 · Cited by 83
John, G. T., Thomas, P. P., Thomas, M., Jeyaseelan, L., Jacob, C. K., & Shastry, J. C. M. (1994) · PubMed · Cited by 78
Singh, N., Wagener, M. M., & Gayowski, T. (2002) · Transplantation · doi:10.1097/00007890-200209270-00029 · Cited by 77
Prospective randomised trial of isoniazid prophylaxis in renal transplant recipient
Agarwal, S. K., Gupta, S. K., Dash, S., Bhowmik, D. M., & Tiwari, S. C. (2004) · International Urology and Nephrology · doi:10.1007/s11255-004-6251-6 · Cited by 70
TUBERCULOSIS IN RENAL TRANSPLANT RECIPIENTS1
Sayıner, A., Ece, T., Duman, S., et al. (1999) · Transplantation · doi:10.1097/00007890-199911150-00009 · Cited by 69
Al-Sulaiman, M. H., Dhar, J. M., & AL-KHADER, A. A. (1990) · Transplantation · doi:10.1097/00007890-199010000-00014 · Cited by 58
Treatment of tuberculosis with rifabutin in a renal transplant recipient
López-Montes, A., Gallego, E., López, E., Pérez, J., Lorenzo, I., Llamas, F., Serrano, A., Andrés, E., Illescas, L., & Gómez, C. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.06.015 · Cited by 57
Lou, H., Shullo, M. A., & McKaveney, T. P. (2002) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.9.701.34065 · Cited by 51
Multidrug-resistant tuberculosis in a lung transplant recipient
Lee, J. J., Yew, W. W., Wong, C. F., Wong, P. C., & Chiu, C. S. W. (2003) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(02)01189-0 · Cited by 51
Tuberculosis Transmitted Through Transplantation
Graham, J., Kearns, A., Magee, J. G., El-Sheikh, M. F. A., Hudson, M., Manas, D. M., Gould, F. K., Orr, K. E., & Freeman, R. J. (2001) · Journal of Infection · doi:10.1053/jinf.2000.0879 · Cited by 50
Isoniazid hepatotoxicity after orthotopic liver transplantation.
Schluger, L. K., Sheiner, P. A., Jonas, M., Guarrera, J. V., Fiel, I., Meyers, B. F., & Berk, P. D. (1996) · PubMed · Cited by 46
Tuberculosis in transplanted lungs.
Dromer, C., Nashef, S. A. M., Velly, J.-F., Martigne, C., & Couraud, L. (1993) · PubMed · Cited by 46
Kunimoto, D. Y., Warman, A., Beckon, A., Doering, D., & Melenka, L. (2003) · Clinical Infectious Diseases · doi:10.1086/375072 · Cited by 41
Rifampin and Ansamycin Interactions with Cyclosporine After Renal Transplantation
Vandevelde, C., Chang, A., Andrews, D. F., Riggs, W. K., & Jewesson, P. J. (1991) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1991.tb03603.x · Cited by 33
Clinical Outcomes of Tuberculosis in Renal Transplant Recipients
Park, Y. S., Choi, J. Y., Cho, C. H., Chang, K. H., Song, Y. G., Kim, Y. S., & Kim, J. M. (2004) · Yonsei Medical Journal · doi:10.3349/ymj.2004.45.5.865 · Cited by 27
Isoniazid prophylaxis in lung transplantation
Román, A., Bravo, C., Levy, G. Y., Monforte, V., Vidal, R., Solé, J., Maestre, J., & Morell, F. (2000) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(00)00163-7 · Cited by 27
Screening for Tuberculosis in the Study of the Living Renal Donor in a Developing Country
ndez, E. H. N.-H., Alber, J., Gonzalez-Michaca, L., Bobadilla-del-Valle, M., Correa‐Rotter, R., & Sifuentes‐Osornio, J. (2006) · Transplantation · doi:10.1097/01.tp.0000188689.41785.d8 · Cited by 26
Isoniazid does not affect bioavailability of cyclosporine in renal transplant recipients
Sud, K., Muthukumar, T., Singh, B., Garg, S. K., Kohli, H. S., Jha, V., Gupta, K. L., & Sakhuja, V. (2000) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2000.22.8.802278 · Cited by 14
Lui, S., Li, F. K., Choy, B. Y., Chan, T. M., Lo, W. K., & Lai, K. N. (2004) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2004.00050.x · Cited by 13
Cited by
KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors
Lentine, K. L., Kasiske, B. L., Levey, A. S., Adams, P. L., Alberú, J., Bakr, M. A., Gallon, L., Garvey, C. A., Guleria, S., Li, P. K.-T., et al. (2017) · Transplantation · doi:10.1097/tp.0000000000001769 · Cited by 582
Lucey, M. R., Terrault, N., Ojo, L., Hay, E. J., Neuberger, J., Blumberg, E., & Teperman, L. W. (2013) · Liver Transplantation · doi:10.1002/lt.23566 · Cited by 544
The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement
Bumbacea, D., Arend, S. M., Eyuboglu, F., Fishman, J. A., Goletti, D., Ison, M. G., Jones, C. E., Kampmann, B., Kotton, C. N., Lange, C., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00000712 · Cited by 264
Self-citationMycobacterial infections in solid organ transplant recipients
Meije, Y., Piersimoni, C., Torre-Cisneros, J., Dilektasli, A. G., & Aguado, J. M. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12641 · Cited by 124
Self-citationKim, D.-S., Yoon, Y.-I., Kim, B. K., Choudhury, A., Kulkarni, A., Park, J. Y., Kim, J., Sinn, D. H., Joo, D. J., Choi, Y., et al. (2024) · Hepatology International · doi:10.1007/s12072-023-10629-3 · Cited by 47
Metadata
- Authors
- Aguado, J. M., Torre‐Cisneros, J., Fortún, J., Benito, N., Meije, Y., Doblas, A., & Muñoz, P.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-05
- Volume
- 48
- Issue
- 9
- Pages
- 1276-1284
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W1969929180
- Cited by
- 257
- References
- 38
- FWCI
- 10.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.